Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Surrozen is a biotechnology company focused on discovering and developing biologic therapeutics that selectively modulate the Wnt signaling pathway to promote tissue repair and regeneration. Its core platform uses proprietary antibody technologies, including Wnt mimetics, to target diseases across multiple organs, with a primary emphasis on ophthalmology. The company aims to address unmet medical needs in severe diseases such as retinal disorders, corneal dystrophies, and tissue injuries through innovative, tissue-specific Wnt pathway activation.
This description was generated via AI from an annual report. Updated about 1 year ago.